bioRxiv: Scientists build first COVID-19 open source all-atomic model

, June 10, 2020 /
bioON/ SARS-CoV-2 is the main cause of COVID-19, the main cause of the adhocytic protein or S protein will promote the virus into the host cell
; In the rxiv
study, scientists from the National Seoul University and others developed the first open-source all-atomic model of the full-length S protein, which plays a key role in the virus's entry into the host cell, which could make it a new target for late researchers to develop vaccines and new antiviral drugsPicture Source: Lehigh University
In the article, the researchers revealed how they built a membrane system for the SARS-CoV-2 S protein model, using a program called CHARMM-GUI to quickly simulate complex biomolecular systems that help scientists understand interactions at the molecular level that other means cannot be observedResearcher Wonpil Im said: 'We developed the first full-length full-length SARS-CoV-2 sting (S) protein model for the Magic Heart format, which can be used by other scientistsResearchers have spent a lot of time building these models using known cryogenic electron microscopes, and building them can be challenging because in many areas simple modeling does not provide high-quality modelsthis study, researchers can use the model for innovative new simulation studies to develop effective therapies for the prevention and treatment of COVID-19, and cryogenic cryoscope technology, in which researchers can determine the structure of the S protein, but the model has many missing residues, so the researchers first need to simulate the missing amino acid residues, but other missing structural domains, the researchers were able to simulate potential polysaccharides that are adsorbed to the S protein, which block the identification of antibodies, making vaccine research difficult, and the researchers have built a s-protein membrane system for molecular dynamic simulation(BioValleyBioon.com)original origins:Hyeonuk Woo, Sang-Jun Park, Yeol Kyo Choi, et al.
Model and Simulation of a Fully-glycosylated Full-length SARS-CoV-2 Spike Protein in a Viral Film,bioRxiv (2020) DOI: 10.1101/2020.05.20.103325